These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35572586)

  • 1. PreS/2-21-Guided siRNA Nanoparticles Target to Inhibit Hepatitis B Virus Infection and Replication.
    Gao L; Yang J; Feng J; Liu Z; Dong Y; Luo J; Yu L; Wang J; Fan H; Ma W; Liu T
    Front Immunol; 2022; 13():856463. PubMed ID: 35572586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel vector preS1-tp fusion protein effectively inhibits hepatitis B virus replication and cccDNA synthesis by mediating hepatitis B virus targeting sequence small interfering RNA].
    Zeng YL; Gao F; Zhang C; Wei JF; Ma L; Ding GG; Li W; Shang J; Kang Y
    Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):126-132. PubMed ID: 33685080
    [No Abstract]   [Full Text] [Related]  

  • 3. Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA.
    Zhuang AQ; Chen Y; Chen SM; Liu WC; Li Y; Zhang WJ; Wu YH
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.
    Laras A; Koskinas J; Dimou E; Kostamena A; Hadziyannis SJ
    Hepatology; 2006 Sep; 44(3):694-702. PubMed ID: 16941694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
    Testoni B; Lebossé F; Scholtes C; Berby F; Miaglia C; Subic M; Loglio A; Facchetti F; Lampertico P; Levrero M; Zoulim F
    J Hepatol; 2019 Apr; 70(4):615-625. PubMed ID: 30529504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo.
    Gorsuch CL; Nemec P; Yu M; Xu S; Han D; Smith J; Lape J; van Buuren N; Ramirez R; Muench RC; Holdorf MM; Feierbach B; Falls G; Holt J; Shoop W; Sevigny E; Karriker F; Brown RV; Joshi A; Goodwin T; Tam YK; Lin PJC; Semple SC; Leatherbury N; Delaney Iv WE; Jantz D; Rhoden Smith A
    Mol Ther; 2022 Sep; 30(9):2909-2922. PubMed ID: 35581938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?
    Gao Y; Li Y; Meng Q; Zhang Z; Zhao P; Shang Q; Li Y; Su M; Li T; Liu X; Zhuang H
    J Clin Microbiol; 2017 Oct; 55(10):2972-2982. PubMed ID: 28747369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatitis B virus cccDNA by siRNA in transgenic mice.
    Li G; Jiang G; Lu J; Chen S; Cui L; Jiao J; Wang Y
    Cell Biochem Biophys; 2014 Jul; 69(3):649-54. PubMed ID: 24569930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B viral DNA decline at loss of HBeAg is mainly explained by reduced cccDNA load--down-regulated transcription of PgRNA has limited impact.
    Malmström S; Larsson SB; Hannoun C; Lindh M
    PLoS One; 2012; 7(7):e36349. PubMed ID: 22911677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
    Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
    J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.
    Qi Y; Gao Z; Xu G; Peng B; Liu C; Yan H; Yao Q; Sun G; Liu Y; Tang D; Song Z; He W; Sun Y; Guo JT; Li W
    PLoS Pathog; 2016 Oct; 12(10):e1005893. PubMed ID: 27783675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Editing Technologies to Target HBV cccDNA.
    Martinez MG; Smekalova E; Combe E; Gregoire F; Zoulim F; Testoni B
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siRNA combinations mediate greater suppression of hepatitis B virus replication in mice.
    Li G; Fu L; Jiang J; Ping Y; Huang Y; Wang Y
    Cell Biochem Biophys; 2014 Jul; 69(3):641-7. PubMed ID: 24549857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models.
    Yi J; Lei X; Guo F; Chen Q; Chen X; Zhao K; Zhu C; Cheng X; Lin J; Yin H; Xia Y
    Antiviral Res; 2023 Jul; 215():105618. PubMed ID: 37142191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA.
    Yan Z; Zeng J; Yu Y; Xiang K; Hu H; Zhou X; Gu L; Wang L; Zhao J; Young JAT; Gao L
    J Hepatol; 2017 Jun; 66(6):1149-1157. PubMed ID: 28213165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
    Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z
    Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure.
    Lucifora J; Protzer U
    J Hepatol; 2016 Apr; 64(1 Suppl):S41-S48. PubMed ID: 27084036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.
    Huang H; Wang J; Li W; Chen R; Chen X; Zhang F; Xu D; Lu F
    J Clin Virol; 2018; 99-100():71-78. PubMed ID: 29353073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of intrahepatic hepatitis B virus covalently closed circular DNA and total DNA in patients with acute hepatitis B and patients with chronic hepatitis B receiving anti‑viral treatment.
    Ruan P; Zhou B; Dai X; Sun Z; Guo X; Huang J; Gong Z
    Mol Med Rep; 2014 Apr; 9(4):1135-41. PubMed ID: 24566465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.